RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
about
S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis RestrictionImpact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-AnalysisScavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyMelanoma Brain Metastasis: Mechanisms, Models, and MedicineMultiple criteria optimization joint analyses of microarray experiments in lung cancer: from existing microarray data to new knowledge.Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progressionMolecular Pathways Involved in the Amelioration of Myocardial Injury in Diabetic Rats by Kaempferol.S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance.Transcriptomic and Proteomic Investigation of HSP90A as a Potential Biomarker for HCC.Identification of metastasis-associated genes in colorectal cancer using metaDE and survival analysisBone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer.Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cellsTumor necrosis factor receptor 2 promotes growth of colorectal cancer via the PI3K/AKT signaling pathway.The role of S100 proteins and their receptor RAGE in pancreatic cancer.Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasisSerum biomarker analysis in patients with recurrent spontaneous abortion.Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis.S100A4 in cancer progression and metastasis: A systematic review.AGER promotes proliferation and migration in cervical cancer.Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.The microRNA miR-124 inhibits vascular smooth muscle cell proliferation by targeting S100 calcium-binding protein A4 (S100A4).Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.Tumor necrosis factor receptor 2 may promote the proliferation and drug resistance of Kapras299 and L428 lymphoma cells via the AKT and WNT/β-catenin signaling pathways.Overexpression of High-Mobility Motor Box 1 in the Blood and Tissues of Patients with Head and Neck Squamous Cell Carcinoma
P2860
Q26743403-33C66EE4-F7C3-4C24-8370-EF5F3636E2CBQ26768261-F1D3F122-54EF-46CD-9162-0EBBF7D35A99Q26799114-3D27227E-93C6-4B02-9744-DFEA61B61222Q28069421-2AE65ABA-B17B-4670-A3AC-9E5D52A5D135Q31005911-AC7BB61F-EC7B-400B-84AA-C48E46F64C45Q33591453-0EA14EAD-E497-499D-BDAC-7DE3E9CCA2CCQ33755103-E9780370-CE2C-4D53-9C99-A2327B041C1BQ34161174-732487B1-6A03-43BB-A865-8DCB81AFA584Q34786561-997A9FCB-2810-4939-8E0C-98701AB4A4DDQ35918946-6140EF2A-B9B0-4CAE-AF4D-AEF4B446AB3FQ36412814-3D025D1E-EA01-4871-BEC2-A34462FDF05DQ36502358-CD7424CC-294E-4003-B861-41287C2C4AE7Q36619033-7D995780-5E18-469F-90ED-78F91B7DBB5BQ36797465-F0C7A2AC-B20D-448E-878B-670619C63007Q37593982-E62787B4-07E9-417B-8D27-6CD11C4B61FFQ38598852-D9B073F6-63B1-4BBA-83D9-F47DA8CFDB0BQ38628054-0E6BBD9B-67CD-455D-8D5F-56C4D445D86DQ38693339-64650FC6-511C-419A-B275-6B9FCBB550B5Q38840062-35F96ED6-B4F9-4E11-A480-9FABB6D8EEA6Q41661771-D19A9491-C04D-43CF-9945-5D1A4A7277D3Q42700673-BBC8EE6A-A496-4312-8AEA-6239F3EE3584Q47234398-57FAB6D9-04D9-4507-858A-9F4FDD6C2E17Q48089252-ED11F1AB-E24A-405C-A3DD-827F700EEF73Q50874003-045B1434-F14D-4D0B-AF3F-E762E5FE6B0EQ52807468-FDBE1F3D-9175-4619-B5BD-BFC3EE40F66CQ52873877-CEDF68CC-BE2B-4DEA-8EC4-F13101D49D36Q55228769-FE74224E-51D4-4D8A-82A0-82147B86FF60Q58774321-081C6CD9-9F1F-4E23-8E41-4AB68D3DBC2B
P2860
RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
RAGE mediates S100A4-induced c ...... colorectal cancer metastasis.
@en
type
label
RAGE mediates S100A4-induced c ...... colorectal cancer metastasis.
@en
prefLabel
RAGE mediates S100A4-induced c ...... colorectal cancer metastasis.
@en
P2093
P2860
P921
P356
P1433
P1476
RAGE mediates S100A4-induced c ...... n colorectal cancer metastasis
@en
P2093
Anna Okhrimenko
Claus W Heizmann
Janice Smith
Marc Osterland
Patrick Marcinkowski
Peter M Schlag
Pia Herrmann
Ulrike Stein
P2860
P304
P356
10.18632/ONCOTARGET.1908
P407
P577
2014-05-01T00:00:00Z